Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

BUY
$35.61 - $76.23 $4,558 - $9,757
128 New
128 $5,000
Q1 2022

Apr 05, 2022

SELL
$57.56 - $82.54 $7,367 - $10,565
-128 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$72.5 - $100.68 $9,280 - $12,887
128 New
128 $10,000
Q3 2021

Oct 22, 2021

SELL
$90.24 - $124.05 $11,550 - $15,878
-128 Closed
0 $0
Q2 2021

Jul 15, 2021

SELL
$93.66 - $139.27 $2,528 - $3,760
-27 Reduced 17.42%
128 $16,000
Q1 2021

Apr 16, 2021

BUY
$116.57 - $155.01 $3,147 - $4,185
27 Added 21.09%
155 $20,000
Q4 2019

Feb 06, 2020

BUY
$77.66 - $99.74 $9,008 - $11,569
116 Added 966.67%
128 $12,000
Q1 2019

May 01, 2019

BUY
$61.98 - $96.5 $743 - $1,158
12 New
12 $1,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Trust CO Of Vermont Portfolio

Follow Trust CO Of Vermont and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.